Abstract OT3-17-01: OPTIMA: A prospective randomized trial to validate the clinical utility and cost-effectiveness of gene expression test-directed chemotherapy decisions in mostly node-positive early breast cancer

Robert C Stein, Andrea Marshall, Andreas Makris, Luke Hughes-Davies, Iain R MacPherson, Carmel Conefrey, Leila Rooshenas, Sarah E Pinder, Abeer M Shaaban, Bjørn Naume, David A Cameron, Daniel W Rea, Helena M Earl, Christopher J Poole, Peter S Hall, Georgina Dotchin, Stuart A McIntosh, Victoria Harmer, Adrienne Morgan, Bethany ShinkinsNigel Stallard, Christopher McCabe, Jenny L Donovan, John MS Bartlett, Janet A Dunn

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished - 14 Feb 2020
Event42nd San Antonio Breast Cancer Symposium - San Antonio, San Antonio, United States
Duration: 10 Dec 201914 Dec 2019


Conference42nd San Antonio Breast Cancer Symposium
Abbreviated titleSABCS
Country/TerritoryUnited States
CitySan Antonio

Cite this